Albireo Pharma Inc (NASDAQ:ALBO)

33.49
Delayed Data
As of 4:00pm ET
 +0.06 / +0.18%
Today’s Change
15.31
Today|||52-Week Range
39.87
+30.82%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close33.43
Today’s open33.43
Day’s range33.24 - 34.75
Volume112,817
Average volume (3 months)61,218
Market cap$368.4M
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)+76.35%
Earnings growth (this year)+4.52%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-99.99%
P/E ratioNM
Price/Sales200,174.00
Price/Book4.21

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...-0.08-1.83%
SBBPStrongbridge Biophar...-0.05-0.73%
NEOSNeos Therapeutics In...-0.20-3.01%
CMRXChimerix Inc+0.08+1.73%
Data as of 4:00pm ET, 06/19/2018

Financials

Next reporting dateAugust 20, 2018
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$1.0K
Annual profit (last year)-$24.4M
Net profit margin-2,441,400.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Ronald H. W. Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts